The Real Economy Blog

Home > Coronavirus > CHART OF THE DAY: The race to find a coronavirus vaccine

CHART OF THE DAY: The race to find a coronavirus vaccine

by

Scientists have been working at a blistering pace to shorten the vaccine development cycle from years to months in order to take a coronavirus vaccine to market. With more than 190 such vaccines in development, there are several leading the pack.

Two trials, by AstraZeneca and Johnson & Johnson, had been halted because participants had become sick. But both were cleared to resume in recent days.

Here’s the latest on the development of vaccines, as of Oct. 15, according to The New York Times and the World Health Organization:

For more information on how the coronavirus is affecting midsize businesses, please visit the RSM Coronavirus Resource Center.

Related posts

About Adam Lohr

Adam is an audit partner and life sciences senior analyst in RSM's cutting-edge industry eminence program. In addition to providing assurance services to his clients, he sits on RSM’s national life science team and leads the San Diego office life science practice.

His senior analyst responsibilities include advising the firm’s life sciences care clients and client servers as they work to navigate the rapidly changing industry environment. Adam regularly writes, presents and advises on capital markets, digital transformation, policy and other issues transforming life sciences. He is an instructor at the regional and national level, and is experienced in the application of ASC 606 revenue recognition for the technology and consumer products industries.

Adam has over 12 years of accounting and finance experience, serving private equity-backed and private closely held companies in the middle market. He specializes in providing financial audit services and helping clients respond to technical, regulatory and economic changes that impact their business.